Posts by: Alice Melão

News, PAH News

Celgene has given Acceleron Pharma the global rights to develop and commercialize sotatercept as a treatment for pulmonary arterial hypertension (PAH) and other lung diseases. Acceleron obtained the rights under a revision of ... Read more

September 7, 2017September 7, 2017

Tracleer Becomes First FDA-approved Therapy in U.S. for Children with Pulmonary Hypertension

News, PAH News

Tracleer (bosentan) has become the first therapy to obtain U.S. regulatory approval for treating pulmonary hypertension in children. The Food and Drug Administration authorized it for children aged 3 and older who ... Read more

August 23, 2017August 23, 2017

VMS Heart Analysis System Accurately Evaluates Right Ventricle Remodeling in PH Patients, Study Shows

News, PAH News, PH News

Ventripoint Diagnostics‘ VMS Heart Analysis System, which produces a two-dimensional (2D) volumetric reconstruction model of the heart, accurately measures small changes in the heart’s right ventricle volume and can be used in ... Read more

August 14, 2017August 14, 2017

Tracking Long-term Changes in PAH Patients’ Heart Conditions Could Help Reduce Deaths, Study Suggests

News, PAH News

Tracking long-term changes in measurements associated with pulmonary hypertension patients’ death from heart disease can help doctors do a better job of identifying those at higher risk of such ... Read more

July 28, 2017July 28, 2017

Complexa Raises $62 Million to Continue Trials of Its Pulmonary Hypertension Therapy CXA-10

News, PAH News

Complexa has obtained $62 million in financing to continue advancing its pulmonary arterial hypertension therapy CXA-10 through the clinical trial process. The company is also developing CXA-10 as a treatment ... Read more

July 21, 2017July 21, 2017

Obese Patients with PAH Have Lower Risk of Dying While Hospitalized, Study Finds

News, PAH News

Obese people with pulmonary arterial hypertension (PAH) are less likely than patients of normal weight to die while hospitalized, finds a study examining the so-called “obesity paradox.” The study, ... Read more

July 18, 2017July 18, 2017

Mount Sinai, Theragene Form Partnership to Move Potential PH Gene Therapy to Clinical Development

News, PH News

New York’s Mount Sinai and Theragene Pharmaceuticals have joined efforts to move a novel investigational aerosol-delivered gene therapy to treat pulmonary hypertension (PH) into a clinical development program. The new therapy, ... Read more

July 12, 2017July 12, 2017

Extended Release Formulation of PAH Therapy Ralinepag Shows Promise in Phase 1 Trial

News, PAH News

Results of a Phase 1 clinical study in healthy volunteers evaluating different formulations of Arena Pharmaceuticals’ prostacyclin receptor agonist, ralinepag, for the treatment of pulmonary arterial hypertension (PAH), showed ... Read more

July 10, 2017July 10, 2017

Adipsin Protein Is a Biomarker of PAH Associated with Systemic Sclerosis, Study Finds

News, PAH News, PH News

Elevated levels of a protein called adipsin, produced by adipose or fat tissue, was found to be associated with an increased risk of pulmonary arterial hypertension (PAH) and associated cardiovascular ... Read more

June 26, 2017June 26, 2017

Echocardiograms Can Help Identify PAH Patients at High Risk of Death, Study Reports

News

High blood pressure in the right artery makes a person with pulmonary arterial hypertension almost 2 1/2 times more likely to die than a patient with lower pressure, according ... Read more